MoneyWorks4Me

The sales surged to Rs. 1234.45 millions, up 46.25% for the December 2025 quarter as against Rs. 844.07 millions during the corresponding quarter previous year.Profit for the quarter ended December 2025 rises by 87.45% to Rs. 160.06  millions from Rs. 85.39 millions.Operating profit for the quarter ended December 2025 rose to 304.81 millions as compared to 181.60 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1234.45 844.07 46.25 3462.37 2545.20 36.04 3701.97 3071.72 20.52
Other Income 5.28 6.55 -19.39 18.01 11.55 55.93 19.20 18.30 4.92
PBIDT 304.81 181.60 67.85 812.90 556.98 45.95 823.64 684.63 20.30
Interest 24.82 22.01 12.77 80.84 73.86 9.45 98.78 103.87 -4.90
PBDT 271.70 159.59 70.25 723.77 483.12 49.81 724.86 509.77 42.19
Depreciation 48.18 45.48 5.94 145.34 131.80 10.27 182.58 195.11 -6.42
PBT 223.52 114.11 95.88 578.43 351.32 64.64 542.28 314.66 72.34
TAX 63.46 28.72 120.96 157.89 97.42 62.07 143.38 74.83 91.61
Deferred Tax 0.25 0.03 733.33 9.58 -0.03 -32033.33 -15.89 -4.37 263.62
PAT 160.06 85.39 87.45 420.54 253.90 65.63 398.90 239.83 66.33
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 24.69 21.51 14.77 23.48 21.88 7.29 22.25 22.29 -0.18
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..